[1]DANNY C.Precision cancer therapeutics for glioma[J].Glioma,2018,1(5):155-158.
[2]WANG FF,PIROZZI C,LI XJ.Glioma research in the era of medical big data[J].Cancer Translational Medicine,2018,4(4):95-101.
[3]HAASE S,GARCIA-FABIANI MB,CARNEY S,et al.Mutant ATRX:Un-covering a new therapeutic target for glioma[J].Expert Opinion on Therapeutic Targets,2018,22(7):599-613.
[4]BOUSSIOTIS VA,CHAREST A.Immunotherapies for malignant glioma[J].Oncogene,2018,37(9):1121-1141.
[5]RAMANUJAM D,SCHON AP,BECK C,et al.MicroRNA-21-dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload[J].Circulation,2021,143(15):1513-1525.
[6]ZHANG C,WANG Q,ZHOU X,et al.MicroRNA-138 modulates glioma cell growth,apoptosis and invasion through the suppression of the AKT/mTOR signalling pathway by targeting CREB1[J].Oncol Rep,2020,44(6):2559-2568.
[7]ZHOU LL,ZHANG M,ZHANG YZ,et al.Long non-coding RNA PSMA3-AS1 enhances cell proliferation,migration and invasion by regulating miR-302a-3p/RAB22A in glioma[J].Biosci Rep,2020,40(9):BSR20191571.
[8]LI B,CHANG H,LIN YC,et al.Cutaneous metastases of the glioma[J].The Journal of Craniofacial Surgery,2018,29(1):E94-E96.
[9]HUANG H,YU X,HAN X,et al.Piwil1 regulates glioma stem cell maintenance and glioblastoma progression[J].Cell Rep,2021,34(1):108522.
[10]XU S,TANG L,LI X,et al.Immunotherapy for glioma:Current management and future application[J].Cancer Lett,2020,476:1-12.
[11]郭劲松,金延方.脑胶质瘤手术后后续治疗效果的评价与展望[J].中国医刊,2014,49(5):27-30.
GUO JS,JIN YF.Evaluation and prospect of follow-up treatment for glioma after operation[J].Chinese Journal of Medicine,2014,49(5):27-30.
[12]ZHAO JL,TAN B,CHEN G,et al.Hypoxia-induced glioma-derived exosomal miRNA-199a-3p promotes ischemic injury of peritumoral neurons by inhibiting the mTOR pathway[J].Oxid Med Cell Longev,2020,2020:5609637.
[13]YU DH,CHEN C,LIU XP,et al.Dysregulation of miR-138-5p/RPS6KA1-AP2M1 is associated with poor prognosis in AML[J].Front Cell Dev Biol,2021,9:641629.
[14]SONG T,ZHANG X,WANG C,et al.MiR-138 suppresses expression of hypoxia-inducible factor 1α(HIF-1α) in clear cell renal cell carcinoma 786-O cells[J].Asian Pac J Cancer Prev,2011,12(5):1307-1311.
[15]MA F,ZHANG M,GONG W,et al.MiR-138 suppresses cell proliferation by targeting Bag-1 in gallbladder carcinoma[J].PLoS One,2015,10(5):e0126499.
[16]VAN DER AUWERA I,LIMAME R,VAN DAM P,et al.Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype[J].Br J Cancer,2010,103(4):532-541.
[17]MESA R,SALOMON C,ROGGERO M,et al.Rab22a affects the morphology and function of the endocytic pathway[J].J Cell Sci,2001,114(Pt22):4041-4049.
[18]MAGADAN JG,BARBIERI MA,MESA R,et al.Rab22a regulates thesorting of transferrin to recycling endosomes[J].Mol Cell Biol,2006,26(7):2595-2614.
[19]MESA R,MAGADAN JG,BARBIERI MA,et al.Overexpression of Rab22a hampers the transport between endosomes and the golgi apparatus[J].Exp Cell Res,2005,304(2):339-353.
[20]WANG T,GILKES DM,TAKANO N,et al.Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis[J].Proc Natl Acad Sci USA,2014,111(31):E3234-3242.
[21]OKAMOTO I,PIRKER C,BILBAN M,et al.Seven novel and stable trans-locations associated with oncogenic gene expression in malignant melanoma[J].Neoplasia,2005,7(4):303-311.
[22]HE H,DAI F,YU L,et al.Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues[J].Gene Expr,2002,10(5-6):231-242.
[23]YANG D,LIU G,WANG K.miR-203 acts as a tumor suppressor gene in osteosarcoma by regulating RAB22A[J].PLoS One,2015,10(9):e0132225.
[24]YANG Z,HE M,WANG K,et al.Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A[J].Int J Clin Exp Pathol,2014,7(11):7563-7570.
[25]ZHANG Y,ZHAO FJ,CHEN LL,et al.MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer[J].Oncotarget,2014,5(23):12291-12303.
[26]ZHANG B,YIN Y,HU Y,et al.MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A[J].Med Oncol,2015,32(1):331.
[27]YIN Y,ZHANG B,WANG W,et al.miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A[J].Clin Cancer Res,2014,20(23):6187-6199.
[28]LIN S,GREGORY RI.MicroRNA biogenesis pathways in cancer[J].Nat Rev Cancer,2015,15(6):321-333.
[29]张灵敏,崔曼莉,杜召召,等.miR-520a调控RAB22A表达并抑制结肠癌细胞的增殖和侵袭[J].现代肿瘤医学,2019,27(22):3949-3954.
ZHANG LM,CUI ML,DU ZZ,et al.miR-520a inhibits cells proliferation and invasion through regulating RAB22A expression in colon cancer[J].Modern Oncology,2019,27(22):3949-3954.